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Background
Methods Results
Healthy subjects (n=20) performed two identical counterbalanced 
sessions, one in which they received 400 µm SVS and one with 0 µm 
SVS. The protocol was as follows:
1. Familiarization/baseline of 4 functional tasks: Each task was 
performed 3-5 times or until performance was consistent
2. Motion sickness induction: Walk the obstacle course while 
wearing up/down reversing prisms (forward twice, reverse twice, 
forward once, reverse once) then read poster while making large 
up/down head movements at 1.33 Hz. Every 2 minutes subjects 
reported MS symptoms, this lasted 30 minutes or until MS=8.
3. Post-motion sickness task performance: Perform each task 
again after motion sickness induction.
Up: SVS was delivered with electrodes 
placed behind the mastoid bone. 
Electrode gel, electrodes, and positioning 
are shown above.
Left: Up/down reversing 
prism goggles used for 
motion sickness induction, 
pressure insoles, and body 
kinematic sensors used to 
record body movement.
Signal passes threshold
Upon return from long-duration spaceflight, 100% of
crewmembers experience motion sickness (MS)
symptoms. The interactions between crewmembers’
adaptation to a gravitational transition, the performance
decrements resulting from MS and/or use of
promethazine (PMZ), and the constraints imposed by
mission task demands could significantly challenge and
limit an astronaut’s ability to perform functional tasks
during gravitational transitions.
Stochastic resonance (SR) is “noise benefit”: adding noise
to a system might increase the information (examples to
the left and above). Stochastic vestibular stimulation (SVS),
or low levels of noise applied to the vestibular system,
improves balance and locomotor performance (Goel et al.
2015, Mulavara et al. 2011, 2015).
In hemi-lesioned rat models, Samoudi et al. 2012
found that SVS increased GABA release on the
lesioned, but not the intact side. Activation of the
GABA pathway is important in modulating MS and
promoting adaptability (Cohen 2008) and was seen
to reverse MS symptoms in rats after unilateral
labyrinthectomy (Magnusson et al. 2000). Thus,
SVS could be used to promote GABA pathways to
reduce MS and promote adaptability, eliminate the
need for PMZ or other performance-inhibiting drugs.
SVS Profile 0-30 Hz, 400 µA
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Without SVS, only 40% of subjects lasted the full
30-minute MS induction protocol, while 65% of
subjects lasted the full 30 minutes with SVS,
which is nearly a significant increase (p=0.056).
On average, subjects lasted 22.6 minutes
without SVS and lasted 24.7 minutes with SVS.
Subjects showed significant improvement from
baseline when performing the prone-to-stand 
test. The results are promising and future work 
includes comparing MS progression between 
PMZ and SVS directly in subjects that are 
provoked to a minimum of nausea. Low levels 
of SVS stimulation may serve as a 
non-pharmacological countermeasure to replace or reduce the PMZ dosage 
requirements and concurrently improve functional performance during transitions to 
new gravitational environments after spaceflight. 
MS symptoms appear to progress
earlier, then plateau with SVS, while they
steadily increase in severity without SVS.
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